NEA Management Company, LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 102 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$12,767,933
-43.2%
4,448,7570.0%0.99%
-42.5%
Q2 2023$22,466,223
+244.7%
4,448,757
+29.0%
1.72%
+280.3%
Q1 2023$6,518,151
+5.0%
3,448,7570.0%0.45%
+29.2%
Q4 2022$6,207,763
+6.5%
3,448,757
-0.0%
0.35%
+19.9%
Q3 2022$5,830,000
-31.3%
3,449,8450.0%0.29%
-33.3%
Q2 2022$8,487,000
-11.2%
3,449,8450.0%0.44%
+58.0%
Q1 2022$9,556,000
-48.0%
3,449,8450.0%0.28%
-25.8%
Q4 2021$18,388,000
-37.0%
3,449,8450.0%0.37%
+7.2%
Q3 2021$29,186,000
-30.6%
3,449,8450.0%0.35%
-36.7%
Q2 2021$42,054,000
-49.8%
3,449,8450.0%0.55%
-70.8%
Q1 2021$83,693,000
-24.3%
3,449,8450.0%1.88%
-35.6%
Q4 2020$110,568,000
+6.0%
3,449,8450.0%2.92%
-33.9%
Q3 2020$104,289,000
-28.3%
3,449,8450.0%4.42%
-24.5%
Q2 2020$145,445,000
+69.0%
3,449,8450.0%5.85%
+30.0%
Q1 2020$86,074,0003,449,8454.50%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2021
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,014,858$17,046,0000.60%
NEA Management Company, LLC 3,449,845$29,186,0000.35%
MPM BioImpact LLC 248,506$2,102,0000.33%
Artal Group S.A. 1,646,517$13,930,0000.31%
RA Capital Management 2,589,904$21,911,0000.30%
Bellevue Group AG 3,463,000$29,297,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 760,128$6,431,0000.13%
Ikarian Capital, LLC 150,484$1,272,0000.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 44,000$371,0000.09%
Virtus ETF Advisers LLC 16,600$140,0000.06%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders